medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Number 3

<< Back

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (3)

Churg Strauss syndrome associated with antileukotriene drugs

Poletti ED, Zepeda-López P, Chávez M, Muñoz-Fernández L

Language: Spanish
References: 25
Page: 209-214
PDF size: 1192.16 Kb.


ABSTRACT

Adult male patient with rhinoconjunctivitis and asthma since childhood, who developed an acute event with fever, cough, dyspnea and extensive cutaneous ulcers in lower extremities. The collateral clinical manifestations and diverse findings (eosinophilia, pulmonary eosinophilic vasculitis, p-ANCA, pulmonary radiographic abnormalities, among others) combined with recent administration of antileukotriene drugs (montelukast), established diagnosis of Churg Strauss syndrome, which was precipitated by lowering of his customary steroid treatment.


REFERENCES

  1. Provost TT, Flynn JA. “Cutaneous medicine”. Cutaneous manifestations of systemic disease. 1a. ed. Hamilton, BC Decker. 2001; 173-204.

  2. Vera-L O, Halabe-Cherem J, Poletti–Vázquez ED, Galarza-Delgado DA et al. Vasculitis. 1a. ed. México, Alfil. 2005; 189-200.

  3. Sneller MC, Langford CA, Fauci AS. “Síndromes de las vasculitis”. En Harrison, Principios de medicina interna. 16a. ed. Barcelona, McGraw- Hill. 2005; 2203-2215.

  4. Wolf, K. Goldsmith LA, Katz SI, Gilchrest AS, Paller DJ, Leffell DJ. Fitzpatrick´s dermatology in general medicine. 7a. ed. Nueva York, McGraw-Hill Medical. 2008; 355-361.

  5. Chen KR, Ohata Y, Sakurai M, Nakayama H. “Churg-Strauss syn - drome: Report of a case without preexisting asthma”. J Dermatol 1992; 19:40-47.

  6. Sontheimer RD, Provost TT. Cutaneous manifestations of rheumatic diseases. 2a. ed. Filadelfia, Lippincott, Williams & Wilkins. 2004; 159-196.

  7. Csernok E, Gross WL. “Primary vasculitides and vasculitis confined to skin: clinical features and new pathogenic aspects”. Arch Dermatol Res 2000; 292: 427-436.

  8. Noth I, Strek ME, Leff AR. “Churg-Strauss syndrome”. Lancet 2003; 361: 587-594.

  9. Lanham JG, Elkon KB, Pusey CD, Hughes GR. “Systemic vasculitis with asthma and eosinophilia: A clinical approach to the Churg- Strauss syndrome”. Medicine (Baltimore) 1984; 63: 65-81.

  10. Eustace JA, Nadasdy T, Choi M. “Disease of the month: The Churg- Strauss syndrome”. J Am Soc Neprhorl 1999; 10: 2048-2055.

  11. Sorensen SF, Slot O, Tvede N, Petersen J. “A prospective study of vasculitis patients collected in a five year period: Evaluation of the Chapel Hill nomenclature”. Ann Rheum Dis 2000; 59: 478-482.

  12. Schwartz RA, Churg J. “Churg-Strauss syndrome”. Br J Dermatol 1992; 127: 199-204.

  13. Davis MD, Daoud MS, McEvoy MT, Su WP. “Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation”. J Am Acad Dermatol 1997; 37: 199-203.

  14. Ruelas Villavicencio AL, López-Tintos B, Orozco-Topete R. “Cu - taneous vasculitis: Etiologic associations and histological findings in a series of Hispanic patients”. J Am Acad Dermatol 2008 , 58(2, supl. 2): AB97.

  15. Chen KR, Su WP, Pittelkow MR, Leiferman KM. “Eosinophilic vasculitis syndrome: Recurrent cutaneous eosinophilic necrotizing vasculitis”. Semin Dermatol 1995; 14: 106-110.

  16. Callen JP, Jorizzo J, Bolognia J, Piette WW, Zone JJ, Dermatological signs of internal medicine, 3a. ed. Filadelfia, Saunders. 2003; 343-351.

  17. Bolognia JL, Jorizzo JL, Rapini RP et al. Dermatology, 2a. ed. Londres, Mosby-Elsevier. 2008; 310-311.

  18. Jaworsky C. “Leukotriene receptor antagonists and Churg-Strauss syndrome: An association with relevance to dermatopathology?” J Cutan Pathol 2008; 35: 611-613. 19.Wechsler ME, Garpestad E, Flier SR et al. “Pulmonary infiltrates, eosinophilia and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast”. J Am Med Assoc 1998; 279: 455.

  19. 20.Green RL, Vayonis AG. “Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment”. Lancet 1999; 353: 725.

  20. Kinoshita M, Shiraishi T, Koga T et al. “Churg-Strauss syndrome after corticosteroid withdrawal in an asthmatic treated with pranlukast”. J Allergy Clin Immunol 1999; 103: 534

  21. Cuchacovich R, Justiniano M, Espinoza LR. “Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA)”. Clin Rheumatol 2007; 26: 1769.

  22. Wechsler ME, Finn D, Gunawardena D, et al. “Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma”. Chest 2000; 117: 708.

  23. 24.Henderson WR, Jr. “The role of leukotrienes in inflammation”. Ann Intern Med 1994; 121: 684.

  24. Seo P, Stone JH. “The antineutrophil cytoplasmic antibody-associated vasculitides”. Am J Med 2004; 117: 39-50.

  25. 26.Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC et al. “Predictors of relapse and treatment resistance in antineutrophil cytoplasmicantibody- associated small-vessel vasculitis”. Ann Intern Med 2005; 143: 621-631.




2020     |     www.medigraphic.com